CTNNB1 and hepatocellular carcinoma: However, recurring alterations exist, such as telomerase reactivation, which occurs in 80% of HCC cases, and the activation of the Wingless-related integration site (Wnt)–catenin beta 1 (CTNNB1) signaling pathway, observed in 30–50% of cases.